36B6:F:F-iShares MSCI USA SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 9.27

Change

+0.06 (+0.66)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.13 (-0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.39 (+0.78%)

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.26 (-0.47%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.25 (+1.39%)

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.57%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

-0.65 (-0.64%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.94 (-0.92%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.21%)

USD 40.47B
0ZC:F Zscaler Inc

-2.88 (-1.64%)

USD 37.92B

ETFs Containing 36B6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.28% 49% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.28% 47% F 52% F
Trailing 12 Months  
Capital Gain 21.08% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.08% 72% C 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.03% 56% F 59% D-
Dividend Return 3.03% 54% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.87% 70% C- 88% B+
Risk Adjusted Return 38.47% 61% D- 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike